Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ThermaCare sale a wrap

This article was originally published in The Tan Sheet

Executive Summary

Wyeth Consumer Healthcare owns the heat wrap ThermaCare after closing the acquisition for an undisclosed amount from Procter & Gamble Sept. 2. Wyeth previously said it sees "tremendous synergy between ThermaCare and Advil," and "significant growth potential" in the heat wrap (1"The Tan Sheet" July 21, 2008, p. 8)

You may also be interested in...



Chattem Launching ACT, Icy Hot Line Extensions, Raises Guidance

Chattem says planned launches of line extensions for ACT,Icy Hot and other products in part prompted it to set its fiscal 2009 guidance at 60 cents to 75 cents per share above its 2008 guidance

Top-Selling ThermaCare Heats Up Wyeth’s Pain-Management Synergy Plans

Wyeth Consumer Healthcare will expand its OTC pain management line by buying category-leading heat wrapThermaCare from Procter & Gamble for an undisclosed amount

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102085

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel